Literature DB >> 22411320

Caveolins and lung function.

Nikolaos A Maniatis1, Olga Chernaya, Vasily Shinin, Richard D Minshall.   

Abstract

The primary function of the mammalian lung is to facilitate diffusion of oxygen to venous blood and to ventilate carbon dioxide produced by catabolic reactions within cells. However, it is also responsible for a variety of other important functions, including host defense and production of vasoactive agents to regulate not only systemic blood pressure, but also water, electrolyte and acid-base balance. Caveolin-1 is highly expressed in the majority of cell types in the lung, including epithelial, endothelial, smooth muscle, connective tissue cells, and alveolar macrophages. Deletion of caveolin-1 in these cells results in major functional aberrations, suggesting that caveolin-1 may be crucial to lung homeostasis and development. Furthermore, generation of mutant mice that under-express caveolin-1 results in severe functional distortion with phenotypes covering practically the entire spectrum of known lung diseases, including pulmonary hypertension, fibrosis, increased endothelial permeability, and immune defects. In this Chapter, we outline the current state of knowledge regarding caveolin-1-dependent regulation of pulmonary cell functions and discuss recent research findings on the role of caveolin-1 in various pulmonary disease states, including obstructive and fibrotic pulmonary vascular and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411320      PMCID: PMC3449096          DOI: 10.1007/978-1-4614-1222-9_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  168 in total

Review 1.  Caveolae as potential macromolecule trafficking compartments within alveolar epithelium.

Authors:  M Gumbleton
Journal:  Adv Drug Deliv Rev       Date:  2001-07-28       Impact factor: 15.470

2.  Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.

Authors:  M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

3.  Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung.

Authors:  T A John; S M Vogel; R D Minshall; K Ridge; C Tiruppathi; A B Malik
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

4.  The cyclin D1 gene is transcriptionally repressed by caveolin-1.

Authors:  J Hulit; T Bash; M Fu; F Galbiati; C Albanese; D R Sage; A Schlegel; J Zhurinsky; M Shtutman; A Ben-Ze'ev; M P Lisanti; R G Pestell
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

5.  In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation.

Authors:  M Bucci; J P Gratton; R D Rudic; L Acevedo; F Roviezzo; G Cirino; W C Sessa
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

6.  Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype.

Authors:  S J Hirst; C H Twort; T H Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2000-09       Impact factor: 6.914

7.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Authors:  B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

8.  Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains.

Authors:  F Galbiati; D Volonte; A M Brown; D E Weinstein; A Ben-Ze'ev; R G Pestell; M P Lisanti
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

9.  Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis.

Authors:  M W Geraci; M Moore; T Gesell; M E Yeager; L Alger; H Golpon; B Gao; J E Loyd; R M Tuder; N F Voelkel
Journal:  Circ Res       Date:  2001-03-30       Impact factor: 17.367

10.  Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway.

Authors:  R D Minshall; C Tiruppathi; S M Vogel; W D Niles; A Gilchrist; H E Hamm; A B Malik
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

View more
  22 in total

1.  Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo.

Authors:  Cory D Sago; Melissa P Lokugamage; Gwyneth N Lando; Naima Djeddar; Nirav N Shah; Chris Syed; Anton V Bryksin; James E Dahlman
Journal:  Nano Lett       Date:  2018-09-20       Impact factor: 11.189

2.  Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling.

Authors:  Suellen D S Oliveira; Maricela Castellon; Jiwang Chen; Marcelo G Bonini; Xiaowu Gu; Michael H Elliott; Roberto F Machado; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

3.  Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation.

Authors:  Jing Huang; John H Wolk; Michael H Gewitz; James E Loyd; James West; Eric D Austin; Rajamma Mathew
Journal:  World J Cardiol       Date:  2015-10-26

Review 4.  Caveolins as Regulators of Stress Adaptation.

Authors:  Jan M Schilling; Brian P Head; Hemal H Patel
Journal:  Mol Pharmacol       Date:  2018-01-22       Impact factor: 4.436

5.  Caveolin-1 scaffolding domain peptide prevents hyperoxia-induced airway remodeling in a neonatal mouse model.

Authors:  Elizabeth R Vogel; Logan J Manlove; Ine Kuipers; Michael A Thompson; Yun-Hua Fang; Michelle R Freeman; Rodney D Britt; Arij Faksh; Binxia Yang; Y S Prakash; Christina M Pabelick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-05-01       Impact factor: 5.464

6.  The Aging Human Lung Mucosa: A Proteomics Study.

Authors:  Andreu Garcia-Vilanova; Angélica M Olmo-Fontánez; Juan I Moliva; Anna Allué-Guardia; Harjinder Singh; Robert E Merritt; Diego J Maselli; Jay I Peters; Blanca I Restrepo; Yufeng Wang; Larry S Schlesinger; Joanne Turner; Susan T Weintraub; Jordi B Torrelles
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-10-06       Impact factor: 6.591

7.  Impact of the loss of caveolin-1 on lung mass and cholesterol metabolism in mice with and without the lysosomal cholesterol transporter, Niemann-Pick type C1.

Authors:  Dorothy I Mundy; Adam M Lopez; Kenneth S Posey; Jen-Chieh Chuang; Charina M Ramirez; Philipp E Scherer; Stephen D Turley
Journal:  Biochim Biophys Acta       Date:  2014-04-18

8.  Nitrosation-dependent caveolin 1 phosphorylation, ubiquitination, and degradation and its association with idiopathic pulmonary arterial hypertension.

Authors:  Farnaz R Bakhshi; Mao Mao; Ayesha N Shajahan; Tobias Piegeler; Zhenlong Chen; Olga Chernaya; Tiffany Sharma; W Mark Elliott; Robert Szulcek; Harm Jan Bogaard; Suzy Comhair; Serpil Erzurum; Geerten P van Nieuw Amerongen; Marcelo G Bonini; Richard D Minshall
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 9.  Mitochondrial glutathione: features, regulation and role in disease.

Authors:  Montserrat Marí; Albert Morales; Anna Colell; Carmen García-Ruiz; Neil Kaplowitz; José C Fernández-Checa
Journal:  Biochim Biophys Acta       Date:  2012-10-30

10.  Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.

Authors:  Suellen D S Oliveira; Jiwang Chen; Maricela Castellon; Mao Mao; J Usha Raj; Suzy Comhair; Serpil Erzurum; Claudia L M Silva; Roberto F Machado; Marcelo G Bonini; Richard D Minshall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.